A Study of the Combination of Osimertinib, Platinum and Etoposide for Patients With Metastatic EGFR Mutant Lung Cancers
Clinical trial NCT03567642 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT03567642
- Sponsor
- Memorial Sloan Kettering Cancer Center
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2018-06-12
- Primary completion
- 2027-06-01
- Enrollment
- 11
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.